Skip to content
10-Q

Quarterly Report

DA32 LIFE SCIENCE TECH ACQUISITION CORP.

0001193125-23-143535

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$395.48K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$259.52K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$5.11M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$4.74M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$3.7M
Stockholders Equity restated Q1 2023 · Dec 31, 2021 −$3.39B
Current Liabilities Q1 2023 · Mar 31, 2023 $1.35M
Current Liabilities Q1 2023 · Dec 31, 2022 $1.05M
Total Liabilities Q1 2023 · Mar 31, 2023 $6.95M
Total Liabilities Q1 2023 · Dec 31, 2022 $6.65M
Current Assets Q1 2023 · Mar 31, 2023 $491.11K
Current Assets Q1 2023 · Dec 31, 2022 $928.97K
Total Assets Q1 2023 · Mar 31, 2023 $204.98M
Total Assets Q1 2023 · Dec 31, 2022 $203.86M
Sga Expense Q1 2023 · Mar 31, 2023 $309.99K
Sga Expense Q1 2023 · Mar 31, 2022 $231.51K
Net Income Q1 2023 · Mar 31, 2023 $825.61K
Net Income Q1 2023 · Mar 31, 2022 −$303.36K
Operating Income Q1 2023 · Mar 31, 2023 −$411.86K
Operating Income Q1 2023 · Mar 31, 2022 −$333.37K
Shares Outstanding Q1 2023 · Jun 15, 2021 5.17M sh